- Home
- ETY vs TWST Comparison
ETY vs TWST Comparison
Compare ETY & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETY
- TWST
- Stock Information
- Founded
- ETY 2006
- TWST 2013
- Country
- ETY United States
- TWST United States
- Employees
- ETY N/A
- TWST N/A
- Industry
- ETY Finance Companies
- TWST Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ETY Finance
- TWST Health Care
- Exchange
- ETY Nasdaq
- TWST Nasdaq
- Market Cap
- ETY 2.4B
- TWST 2.3B
- IPO Year
- ETY N/A
- TWST 2018
- Fundamental
- Price
- ETY $15.70
- TWST $35.99
- Analyst Decision
- ETY
- TWST Buy
- Analyst Count
- ETY 0
- TWST 10
- Target Price
- ETY N/A
- TWST $49.10
- AVG Volume (30 Days)
- ETY 247.3K
- TWST 868.6K
- Earning Date
- ETY 01-01-0001
- TWST 08-04-2025
- Dividend Yield
- ETY 7.21%
- TWST N/A
- EPS Growth
- ETY N/A
- TWST N/A
- EPS
- ETY N/A
- TWST N/A
- Revenue
- ETY N/A
- TWST $347,680,000.00
- Revenue This Year
- ETY N/A
- TWST $22.75
- Revenue Next Year
- ETY N/A
- TWST $17.74
- P/E Ratio
- ETY N/A
- TWST N/A
- Revenue Growth
- ETY N/A
- TWST 25.30
- 52 Week Low
- ETY $10.59
- TWST $27.12
- 52 Week High
- ETY $13.46
- TWST $60.90
- Technical
- Relative Strength Index (RSI)
- ETY 62.66
- TWST 50.71
- Support Level
- ETY $15.49
- TWST $34.16
- Resistance Level
- ETY $15.67
- TWST $36.95
- Average True Range (ATR)
- ETY 0.14
- TWST 1.54
- MACD
- ETY -0.02
- TWST -0.32
- Stochastic Oscillator
- ETY 84.62
- TWST 35.12
About ETY Eaton Vance Tax-Managed Diversified Equity Income Fund of Beneficial Interest
Eaton Vance Tax-mgd Dvsf Eq Inc Fd is a diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Its portfolio of investments consists of capital markets, banks, internet and direct marketing retail, biotechnology, media, oil, gas, and consumable fuels, and other sectors.
About TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.